Regulation

Filter

Current filters:

None

Popular Filters

2370 to 2394 of 2741 results

Europe's drug pricing sent askew by economic crash

22-08-2012

The European Union faced further fallout from the global financial crisis this year, and the region's…

EuropeHealthcarePharmaceuticalPricingRegulation

FDA puts back action date on Pfizer's tofacitinib by three months

22-08-2012

Pfizer (NYSE: PFE), the world's largest drugmaker by sales, yesterday revealed that the US Food and Drug…

Anti-Arthritics/RheumaticsNorth AmericaPfizerPharmaceuticalRegulationtofacitinib

NICE says Roche's Avastin in breast cancer does not provide enough benefit to justify its cost

21-08-2012

The latest and final guidance from the UK's drug watchdog the National Institute for Health and Clinical…

AvastinBiotechnologyEuropeOncologyPharmaceuticalPricingRegulationRoche

New approaches for evaluating benefits and risks of obesity drugs from QW

20-08-2012

The USA's George Washington University School of Public Health and Health Services (GW) has released…

HealthcareMetabolicsNorth AmericaPharmaceuticalRegulationResearch

FDA approves expanded use of Boehringer and Lilly's Tradjenta

20-08-2012

German family-owned drug major Boehringer Ingelheim and US partner and Eli Lilly (NYSE: LLY) said on…

Boehringer IngelheimDiabetesEli LillyNorth AmericaPharmaceuticalRegulationTradjenta

AHF calls for Gilead's Quad HIV pill to be put on "prior authorization" status

19-08-2012

In what may be an unprecedented move on drug pricing and access, advocates from the AIDS Healthcare Foundation…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalPricingQuadRegulation

Idenix plunges as FDA puts clinical hold on hepatitis C drug candidate

17-08-2012

US biotech firm Idenix Pharmaceuticals (Nasdaq: IDIX) saw its shares tank 29% to $5.91 in morning trading…

Anti-viralsBiotechnologyIdenix PharmaceuticalsIDX184North AmericaPharmaceuticalRegulationResearch

UK's NICE continues to back Amgen's Xgeva for most cancer patients with bone metastases

17-08-2012

In a final draft guidance issued today, (August 17), the National Institute for Health and Clinical Excellence…

AmgenBiotechnologyEuropePricingRegulationXgeva

FDA calls for Biovest to conduct another Ph III trial of BiovaxID in NHL

16-08-2012

US biotech firm Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

BiotechnologyBiovaxIDBiovest InternationalOncologyRegulationResearch

Venezuelan govt increasing control over pharmaceutical sector

14-08-2012

Venezuela's national government has changed its policy with regard to the pharmaceutical sector. This…

FinancialGenericsPharmaceuticalPricingRegulationSouth America

Medicines Australia sets up new taskforce on transparency for payments to doctors

14-08-2012

Medicines Australia has invited the Australian Medical Association, the Royal Australian College of Physicians,…

Asia-PacificFinancialMarkets & MarketingPharmaceuticalRegulationResearch

EMA explains EU incident management plan for human medicines

14-08-2012

Earlier this week, the European Medicines Agency published the European Union regulatory network incident…

BiotechnologyEuropePharmaceuticalRegulation

Shionogi partner Ildong gains South Korean approval for Pirespa

14-08-2012

Japanese drug major Shionogi (TYO: 4507) says that its South Korean partner Ildong Pharma has received…

Asia-PacificIldong PharmaPharmaceuticalPirespapirfenidoneRegulationRespiratory and PulmonaryShionogi

US FDA accepts Teva's Quartette NDA

13-08-2012

The US Food and Drug Administration has accepted for filing the New Drug Application for Quartette (levonorgestrel/ethinyl…

North AmericaPharmaceuticalQuartetteRegulationReproductiveTeva Pharmaceutical IndustriesWomen's Health

Roche gains FDA approval for Lucentis in diabetic macular edema

13-08-2012

US biotech firm Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) announced on Friday that…

GenentechLucentisNorth AmericaOphthalmicsPharmaceuticalRegulationRoche

New drug import licensing requirements for Ukraine passed by Parliament

12-08-2012

A new law, introducing licensing on the imports of drugs to Ukraine and responsibility of foreign drug…

EuropeLegalMarkets & MarketingPharmaceuticalRegulation

US FDA approves Talon's rare leukemia drug Marqibo

10-08-2012

California, USA-based Talon Therapeutics (OTCBB: TLON) yesterday gained accelerated approval from the…

MarqiboNorth AmericaOncologyPharmaceuticalRegulationTalon TherapeuticsTekmira Pharmaceuticals

UK's NICE delays decision on Roche's Zelboraf, asking for more information

10-08-2012

UK health care watchdog the National Institute for Health and Clinical Excellence (NICE) today (August…

EuropeOncologyPharmaceuticalPricingRegulationRocheZelboraf

US health care reform looks to squeeze players up and down the value chain

09-08-2012

This summer's landmark Supreme Court decision to uphold the USA's Patient Privacy and Affordable Care…

BiotechnologyFinancialHealthcareNorth AmericaPharmaceuticalRegulationResearch

EMA approves GlaxoSmithKline's Votrient for soft tissue sarcomas

09-08-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that the European Medicines Agency has approved Votrient…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

World's first (official) biosimilar antibody goes to reumatoid arthritis

09-08-2012

The end of July 2012 proved exciting for the world of biosimilar manufacturers. However, for the regulatory…

BiotechnologyCellTrionGenericsGlobalinfliximabJohnson & JohnsonMarkets & MarketingRegulationRemicadeRemsima

2370 to 2394 of 2741 results

COMPANY SPOTLIGHT

Menarini

Back to top